Physician profile
John A Ribeiro
NPI 1245295732
$2,977.59
in general payments reported to CMS, 2019-2025
9 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,254 · 2020: $69.10 · 2022: $1,318 · 2023: $43.33 · 2024: $120 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $336.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $2,521.69 | 2019-2022 | |
| Depuy Synthes Sales INC. | $256.15 | 2019-2025 | Na, Monovisc, Tfn-Advance |
| Bioventus LLC | $72.56 | 2024-2025 | Gelsyn-3, Durolane |
| Smith+Nephew, INC. | $34.05 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Arthrex, INC. | $24.00 | 2022 | |
| Davol INC. | $19.16 | 2025 | Phasix Mesh |
| Sanara Medtech INC. | $19.07 | 2022 | |
| Ethicon US, LLC | $16.15 | 2025 | Surgiflo Hemostatic Matrix, Echelon; Endopath, Echelon Endopath |
| Heron Therapeutics, INC. | $14.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ribeiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.